What do systematic reviews say?

Directed stress management (it is unclear whether these interventions replaced standard treatment or were added to standard treatment) vs usual care

The review found no eligible studies for this question.

• Interventions for the management of abdominal pain in Crohn's disease and inflammatory bowel disease 2021 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Self‐directed stress management (it is unclear whether these interventions replaced standard treatment or were added to standard treatment) vs usual care

The review found no eligible studies for this question.

• Interventions for the management of abdominal pain in Crohn's disease and inflammatory bowel disease 2021 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Medicine‐separated moxibustion combined with acupuncture vs wheat bran‐separated moxibustion combined with shallow acupuncture

• Interventions for the management of abdominal pain in Crohn's disease and inflammatory bowel disease 2021 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 102 participants
  Very low

soft non‐manipulative osteopathic treatment vs no intervention

• Interventions for the management of abdominal pain in Crohn's disease and inflammatory bowel disease 2021 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 30 participants
  Very low

Web‐based education vs standard book‐based education

• Interventions for the management of abdominal pain in Crohn's disease and inflammatory bowel disease 2021 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 60 participants
  Very low

Kefir ( Lactobacillus bacteria) vs no intervention

• Interventions for the management of abdominal pain in Crohn's disease and inflammatory bowel disease 2021 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 20 participants
  Very low

Relaxation vs WAIT LIST

The review found no eligible studies for this question.

• Interventions for the management of abdominal pain in ulcerative colitis 2021 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Kefir ( Lactobacillus bacteria) vs no intervention

• Interventions for the management of abdominal pain in ulcerative colitis 2021 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 20 participants
  GRADE not reported

Stellate ganglion block vs sulphasalazine

The review found no eligible studies for this question.

• Interventions for the management of abdominal pain in ulcerative colitis 2021 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Mesalamine vs placebo

Mesalamine showed no clear difference in withdrawals due to adverse events compared with placebo (low certainty).

• Interventions for treating collagenous colitis 2017 · Cochrane Headline outcomes only
  RR 5.92 [0.7, 49.9]
  1 study · 62 participants
  Low

Budesonide vs placebo

It is very uncertain whether budesonide changes withdrawals due to adverse events compared with placebo (very low certainty).

• Interventions for treating collagenous colitis 2017 · Cochrane Headline outcomes only
  RR 0.97 [0.43, 2.17]
  5 studies · 290 participants
  Very low

Boswellia serrata vs placebo

Boswellia serrata extract showed no clear difference in withdrawals due to adverse events compared with placebo (low certainty).

• Interventions for treating collagenous colitis 2017 · Cochrane Headline outcomes only
  RR 2.82 [0.12, 64.39]
  1 study · 31 participants
  Low

Budesonide vs 5‐aminosalicylic acid (5‐ASA) (mesalazine)

Budesonide showed no clear difference in withdrawals due to adverse events compared with mesalazine (low certainty).

• Interventions for treating collagenous colitis 2017 · Cochrane Headline outcomes only
  RR 0.09 [0.01, 1.65]
  1 study · 55 participants
  Low